Search Results 161-170 of 17439 for monoclonal antibody

  1. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as nivolumab, may block tumor growth in ... Monoclonal Antibody, AFM13 Jacksonville, FL. The purpose of this study is to ...

  2. Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

    A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

  3. Eosinophilic esophagitis - Diagnosis and treatment - Mayo Clinic

    Monoclonal antibodies. The Food and Drug Administration (FDA) recently ... Dupilumab is a type of medicine known as a monoclonal antibody. It works to ...

  4. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).

  5. Immune Monitoring and Immunotherapy in Myeloma - Mayo Clinic

    The treatments include IMiDs, proteosome inhibitors, chemotherapy, monoclonal antibodies and stem cell transplantation.To c. Participation eligibility.

  6. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    Cryosurgery kills cancer cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

  7. Chronic Lymphocytic Clinical Trials - Mayo Clinic Research

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.

  8. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    ... monoclonal antibody domvanalimab, the anti-programmed cell death protein 1 (PD-1) monoclonal antibody zimberelimab, and multiagent chemotherapy in the first ...

  9. Mayo Clinic Proceedings: In the Limelight, February 2022

    Interrupting the Progression of COVID-19 by Anti-Spike Monoclonal Antibodies: Outcomes in Two Eras ... Eligibility for anti-spike monoclonal antibody therapy ...

  10. Health Topics - Mayo Clinic News Network

    What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. What is 'flurona' and why ...